AMENDED AND RESTATED SHARE PURCHASE AGREEMENT by and among TOKAI PHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OF OTIC PHARMA, LTD. Dated as of March 2, 2017 Effective as of December 21, 2016Share Purchase Agreement • March 3rd, 2017 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2017 Company Industry JurisdictionTHIS AMENDED AND RESTATED SHARE PURCHASE AGREEMENT (this “Agreement”), is entered into as of March 2, 2017, by and among Tokai Pharmaceuticals, Inc., a Delaware corporation (“Public Company”), Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (“Otic Pharma”), and the shareholders of Otic Pharma identified on the signature page hereto (the “Shareholders”).
SHARE PURCHASE AGREEMENT by and among TOKAI PHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OF OTIC PHARMA, LTD. Dated as of December 21, 2016Share Purchase Agreement • December 22nd, 2016 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 22nd, 2016 Company Industry JurisdictionTHIS SHARE PURCHASE AGREEMENT (this “Agreement”), dated as of December 21, 2016, is entered into by and among Tokai Pharmaceuticals, Inc., a Delaware corporation (“Public Company”), Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (“Otic Pharma”), and the shareholders of Otic Pharma identified on the signature page hereto (the “Shareholders”).